Sumatra Slim Belly Tonic is not just another weight loss supplement, it’s a science-backed solution that aims to reset your ...

D-Bal MAX is a revolutionary new muscle-building supplement that will put you on the fast track to building lean muscle and ...

Tallmadge, Ohio, May 01, 2025 (GLOBE NEWSWIRE) -- Following Over 90 Days of Personal Experience, Here’s What Truly Occurred ...

Bavarian Nordic A/S (OMX: BAVA) announced today that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization in the United Kingdom (UK) for VIMKUNYA ® ...

EnteroBiotix Limited (‘EnteroBiotix’), a clinical-stage biopharmaceutical company focussed on developing best-in-class drugs for gut health, today announced that results from its IMPuLCE Phase 1b ...

Tokyo, Japan and Cambridge, UK, 2 May 2025 – Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) provides an update on operational activities and reports its consolidated results for the first quarter ...

The total number of shares in Orion Corporation is 141,134,278 which, after the conversion, consists of 32,450,742 A shares and 108,683,536 B shares. The number of votes of the company's shares is ...

Jean-Paul Clozel, Chairman of the Board of Idorsia, commented: “The team at Idorsia continues to go the extra mile to secure the company’s future. I would like to thank my colleagues on the Board for ...

CONCORD, Ontario, May 01, 2025 (GLOBE NEWSWIRE) -- Ultrack Systems Inc. (OTC: MJLB) ("Ultrack" or the "Company") is pleased to announce it has entered into a Memorandum of Understanding (MOU) to ...

Comprehensive Healthcare today announced the expansion of its permanent supportive housing program in Sunnyside with the opening of Vista Del Sol-2 (VDS-2), a 20-unit long-term residential housing ...

Institutional investors interested in arranging a meeting with Genelux management can register to attend the conference or contact [email protected]. About Genelux Corporation Genelux is a late ...

Protara Therapeutics, Inc. (Nasdaq: TARA) (“Protara” or the “Company”), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced the ...